Literature DB >> 33786248

Embryonal Rhabdomyosarcoma Presenting as Lung Metastasis in an Adult: An Uncommon Presentation.

Rabia Taseer1,2, Tabeer T Ahmed3.   

Abstract

Rhabdomyosarcoma (RMS) is one of the most common soft tissue sarcomas of adolescents and young adults. Histologically, rhabdomyosarcoma is classified into embryonal, alveolar, pleomorphic, and spindle cell/sclerosing rhabdomyosarcomas with further subcategorization. More than 50% of embryonal rhabdomyosarcoma occur within head and neck. The retroperitoneum and pelvis are less common sites of involvement. Embryonal rhabdomyosarcomas affect mainly, but not exclusively, children between birth and 15 years of age. Alveolar rhabdomyosarcoma tends to affect older patients. The usual metastatic sites include lung, lymph nodes, and bone marrow. We are presenting a case of a 25-year-old male patient with symptoms of breathlessness, easy fatigability, and weight loss. On chest imaging, there were multiple lung nodules. A primary diagnosis of undifferentiated malignant neoplasm was made on lung biopsy. On immunohistochemistry, the malignant cells were positive for myogenin, myoblast determination protein 1 (MyoD1), and desmin. They were negative for neuroendocrine, germ cell, epithelial, melanocytic, and lymphoid markers. Further workup showed an abdominopelvic retroperitoneal mass on abdominal computed tomography (CT) scan. The biopsy on the retroperitoneal mass showed similar morphology and immunohistochemical profile. Unfortunately, the patient's condition deteriorated rapidly in the following weeks, and he passed away.
Copyright © 2021, Taseer et al.

Entities:  

Keywords:  embryonal; lung metastasis; myo d1; myogenin; retroperitoneal; rhabdomyosarcoma

Year:  2021        PMID: 33786248      PMCID: PMC7998057          DOI: 10.7759/cureus.13545

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

1.  Metastatic Rhabdomyosarcoma: Still Room for Improvement.

Authors:  Leonard H Wexler
Journal:  J Clin Oncol       Date:  2015-11-16       Impact factor: 44.544

2.  Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.

Authors:  Bharat Rekhi; Chhavi Gupta; Girish Chinnaswamy; Sajid Qureshi; Tushar Vora; Nehal Khanna; Siddhartha Laskar
Journal:  Ann Diagn Pathol       Date:  2018-08-03       Impact factor: 2.090

Review 3.  The current landscape of rhabdomyosarcomas: an update.

Authors:  Julia Leiner; François Le Loarer
Journal:  Virchows Arch       Date:  2019-11-06       Impact factor: 4.064

4.  Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.

Authors:  Erin R Rudzinski; James R Anderson; Elizabeth R Lyden; Julia A Bridge; Frederic G Barr; Julie M Gastier-Foster; Karen Bachmeyer; Stephen X Skapek; Douglas S Hawkins; Lisa A Teot; David M Parham
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

5.  Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  R Beverly Raney; David O Walterhouse; Jane L Meza; Richard J Andrassy; John C Breneman; William M Crist; Harold M Maurer; William H Meyer; David M Parham; James R Anderson
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

Review 6.  Rhabdomyosarcoma.

Authors:  Stephen X Skapek; Andrea Ferrari; Abha A Gupta; Philip J Lupo; Erin Butler; Janet Shipley; Frederic G Barr; Douglas S Hawkins
Journal:  Nat Rev Dis Primers       Date:  2019-01-07       Impact factor: 52.329

Review 7.  Practical Issues for Retroperitoneal Sarcoma.

Authors:  Vicky Pham; Evita Henderson-Jackson; Matthew P Doepker; Jamie T Caracciolo; Ricardo J Gonzalez; Mihaela Druta; Yi Ding; Marilyn M Bui
Journal:  Cancer Control       Date:  2016-07       Impact factor: 3.302

8.  Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.

Authors:  Nathalie Stock; Frederic Chibon; Matthieu Bui Nguyen Binh; Philippe Terrier; Jean Jacques Michels; Isabelle Valo; Yves Marie Robin; Louis Guillou; Dominique Ranchère-Vince; Anne-Valérie Decouvelaere; Francoise Collin; Isabelle Birtwisle-Peyrottes; Fleur Gregoire; Alain Aurias; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

Review 9.  Rhabdomyosarcoma.

Authors:  Roshni Dasgupta; Jörg Fuchs; David Rodeberg
Journal:  Semin Pediatr Surg       Date:  2016-09-20       Impact factor: 2.754

10.  Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.

Authors:  Emily Hibbitts; Yueh-Yun Chi; Douglas S Hawkins; Frederic G Barr; Julie A Bradley; Roshni Dasgupta; William H Meyer; David A Rodeberg; Erin R Rudzinski; Sheri L Spunt; Stephen X Skapek; Suzanne L Wolden; Carola A S Arndt
Journal:  Cancer Med       Date:  2019-08-27       Impact factor: 4.452

View more
  1 in total

1.  Adult embryonal rhabdomyosarcoma in the nasal cavity; a case report with a review of the literature.

Authors:  Mariwan L Fatah; Abdulwahid M Salh; Ari M Abdullah; Fahmi H Kakamad; Shevan M Mustafa; Suhaib H Kakamad
Journal:  Ann Med Surg (Lond)       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.